TIME TO RETHINK: The old discussions about reporting HIV infection must be reviewed in light of a changing epidemic, says CDC's John Ward. As the AIDS epidemic enters a new phase of changing demographics and combination drug therapy, support is mounting for a national system of HIV case reporting. Even some civil rights activists who previously opposed HIV reporting now are admitting the need for it to help contain the elusive disease. However, the long-debated question of whether HIV-positive
 TIME TO RETHINK: The old discussions about reporting HIV infection must be reviewed in light of a changing epidemic, says CDC's John Ward. |
"We're at a turning point of this epidemic," notes John Ward, chief of HIV/AIDS surveillance in the Atlanta-based Centers for Disease Control and Prevention (CDC). "After 16 years, for the first time we're beginning to change, in a profound way, how we monitor it. Because of that, all the old ...
Add The Scientist as a preferred Google source to see more of our trusted coverage.
When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.
View this Issue
Discover how tissue-resident memory T cells develop within the respiratory tract and how these findings are advancing respiratory virus immunity, vaccine research, and high-throughput immune profiling.
Explore emerging mechanisms of immune checkpoint inhibitor resistance in hepatocellular carcinoma (HCC) and how combination immunotherapy strategies may improve antitumor immune responses and patient-specific treatment approaches.
Learn practical strategies for optimizing sample preparation, fragmentation, library construction, and quality control to generate high-quality next-generation sequencing (NGS) data across a range of sample types.
Learn how bulk T-cell receptor (TCR) repertoire sequencing can reveal clonotype diversity, support immune monitoring, and generate biological insights for translational immunology and biomarker discovery.
European customers can now subscribe to Sino Biological’s newsletter to receive a special gift and unlock access to EliteScience benefits.
Sino Biological’s trial program enables qualified customers to evaluate SuperNuclease Pro in their specific bioprocessing applications, facilitating faster technology assessment and informed decision-making during process development
This release expands on Sino Biological's comprehensive Tau protein product portfolio, designed to accelerate neurodegenerative disease research.
Resipher measures cellular respiration (OCR) continuously in standard 96-well plates inside your incubator, for days to weeks. No media swaps, dyes, or transfers. A live-cell functional readout for drug safety, metabolism, and mitochondrial health.
